Cargando…
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of symptom severity that requires varying amounts of care according to the different stages of the disease. Intervening at the onset of mild to moderate COVID-19 symptoms in the outpatient setting would provide the opportunity to p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411261/ https://www.ncbi.nlm.nih.gov/pubmed/36030796 http://dx.doi.org/10.1016/S1473-3099(22)00433-9 |